# AbCellera Biologics Inc.: Form 8-K, filed Mar 13, 2023

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2023-03-13
- Accepted by EDGAR: Mar 10, 2023, 18:14 ET
- Period: 2023-03-10
- Accession: 0001564590-23-003427
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000156459023003427/abcl-8k_20230310.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000156459023003427/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000156459023003427/abcl-8k_20230310.htm

Filed Mar 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001564590-23-003427. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
